User Fee Bill Clears Senate Committee With Importation, Orphan Drug Amendments

Highlighting the much-less-bipartisan atmosphere than the House, ranking member Burr votes against the package; US FDA’s advice to generic applicants could be contentious issue in reconciling the legislation between the two chambers.